High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases

REFERENCES

• Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. Jul–Aug 2004;218(4):223–236.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB. The natural history of uveitis. Int Ophthalmol. Oct 1990;14(5–6):303–308.
   PubMed Web of Science ®Google Scholar
• ten Doesschate J. Causes of blindness in The Netherlands. Doc Ophthalmol. Jan 29 1982;52(3–4):279–285.
   PubMedGoogle Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. Oct 2000;130(4):492–513.
   PubMed Web of Science ®Google Scholar
• Wakefield D. Methylprednisolone pulse therapy in severe anterior uveitis. Aust N Z J Ophthalmol. Nov 1985;13(4):411–415.
   PubMedGoogle Scholar
• Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. Jun 1986;104(6):847–851.
   PubMedGoogle Scholar
• Werth VP. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids. Arch Dermatol. Dec 1996;132(12):1435–1439.
   PubMedGoogle Scholar
• Roujeau JC. Pulse glucocorticoid therapy: the ‘big shot’ revisited. Arch Dermatol. Dec 1996;132(12):1499–1502.
   PubMedGoogle Scholar
• Danao T, Segal AM. Pulsed suppressive treatment in rheumatoid arthritis: intravenous methylprednisolone and nitrogen mustard. J Rheumatol. Jul 1990;17(7):893–899.
   PubMedGoogle Scholar
• Buttgereit F, Straub RH, Wehling M, Burmester GR. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum. Nov 2004;50(11):3408–3417.
   PubMedGoogle Scholar
• Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y. Evaluation of pulse corticosteroid therapy for Vogt-Koyanagi-Harada disease assessed by optical coherence tomography. Am J Ophthalmol. Sep 2002;134(3):454–456.
   PubMedGoogle Scholar
• Reed JB, Morse LS, Schwab IR. High-dose intravenous pulse methylprednisolone hemisuccinate in acute Behcet retinitis. Am J Ophthalmol. Mar 1998;125(3):409–411.
   PubMed Web of Science ®Google Scholar
• Markomichelakis NN, Halkiadakis I, Papaeythymiou-Orchan S, Giannakopoulos N, Ekonomopoulos N, Kouris T. Intravenous pulse methylprednisolone therapy for acute treatment of serpiginous choroiditis. Ocul Immunol Inflamm. Feb 2006;14(1):29–33.
   PubMedGoogle Scholar
• Kempen JH, Daniel E, Gangaputra S, et al. Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study. Ophthalmic Epidemiol. Jan–Feb 2008;15(1):47–55.
   PubMedGoogle Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. Sep 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc. 1989;84(408): 1065–1073.
   Google Scholar
• Pujari SS, Kempen JH, Newcomb CW, et al. Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. Feb 2010;117(2):356–365.
   PubMed Web of Science ®Google Scholar
• Kacmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. Mar 2010;117(3):576–584.
   PubMed Web of Science ®Google Scholar
• Daniel E, Thorne JE, Newcomb CW, et al. Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol. Mar 2010;149(3):423–432 e421–422.
   PubMed Web of Science ®Google Scholar
• Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. Nov 2009;116(11):2188–2198 e2181.
   PubMedGoogle Scholar
• Pasadhika S, Kempen JH, Newcomb CW, et al. Azathioprine for ocular inflammatory diseases. Am J Ophthalmol. Oct 2009;148(4):500–509 e502.
   PubMedGoogle Scholar
• Warshaw AL, Welch JP, Ottinger LW. Acute perforation of the colon associated with chronic corticosteroid therapy. Am J Surg. Apr 1976;131(4):442–446.
   PubMedGoogle Scholar
• Beck RW, Cleary PA, Anderson MM Jr, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med. Feb 27 1992;326(9):581–588.
   PubMedGoogle Scholar
• Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. May 1 1991;114(9):735–740.
   PubMedGoogle Scholar
• Chan JC, Cockram CS, Critchley JA. Drug-induced disorders of glucose metabolism: mechanisms and management. Drug Saf. Aug 1996;15(2):135–157.
   PubMed Web of Science ®Google Scholar